5 people charged in $600K insider trading scheme tied to Novartis' Chinook acquisition: DOJ
Five people have been charged for allegedly participating in an insider trading scheme tied to Novartis’ $3.2 billion acquisition of Chinook, including a former director of the biotech’s board.
Five people have been charged for allegedly participating in an insider trading scheme tied to Novartis’ $3.2 billion acquisition of Chinook, including a former director of the biotech’s board.
